Zobrazeno 1 - 10
of 487
pro vyhledávání: '"Herrick, AL"'
Autor:
Herrick, AL1 (AUTHOR) ariane.herrick@manchester.ac.uk, Heal, C2 (AUTHOR), Wilkinson, J2 (AUTHOR), Dinsdale, G1 (AUTHOR), Manning, J1 (AUTHOR), Gunnarsson, K3 (AUTHOR), Jakobsson, P-J3 (AUTHOR), Murray, A1 (AUTHOR), Herrick, A L1 (AUTHOR)
Publikováno v:
Scandinavian Journal of Rheumatology. Nov 2021, Vol. 50 Issue 6, p479-484. 6p.
Publikováno v:
Journal of Inflammation Research, Vol 2011, Iss default, Pp 61-66 (2011)
K Binymin1,3, AL Herrick1, GL Carlson2, SJ Hopkins21University of Manchester, Rheumatic Diseases Centre, 2Infection Injury and Inflammation Group, and Brain Injury Research Group, Manchester Academic Health Science Centre and University of Manchester
Externí odkaz:
https://doaj.org/article/25f366d67045490ab125ae119e484262
Autor:
Hughes, M, Moore, T, Manning, J, Wilkinson, J, Watson, S, Samraj, P, Dinsdale, G, Roberts, C, Rhodes, Le, Herrick, Al, Murray, A
Publikováno v:
Hughes, M, Moore, T, Manning, J, Wilkinson, J, Watson, S, Samraj, P, Dinsdale, G, Roberts, C, Rhodes, L, Herrick, A & Murray, A 2019, ' A Feasibility Study of a Novel Low Level Light Therapy for Digital Ulcers in Systemic Sclerosis ', Journal of Dermatological Treatment, pp. 1-30 . https://doi.org/10.1080/09546634.2018.1484875
Background: Locally acting, well-tolerated treatments for systemic sclerosis (SSc) digital ulcers (DUs) are needed. Objectives: Our primary aim was to investigate the safety, feasibility and tolerability of a novel low level light therapy (LTTT). A s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3818::8f93c68939ed719881dff8f49caec46e
https://www.research.manchester.ac.uk/portal/en/publications/a-feasibility-study-of-a-novel-low-level-light-therapy-for-digital-ulcers-in-systemic-sclerosis(9d9170e8-aeb4-4e46-a783-38face1843ea).html
https://www.research.manchester.ac.uk/portal/en/publications/a-feasibility-study-of-a-novel-low-level-light-therapy-for-digital-ulcers-in-systemic-sclerosis(9d9170e8-aeb4-4e46-a783-38face1843ea).html
Autor:
Wilkinson, JD, Leggett, SA, Marjanovic, EJ, Moore, TL, Allen, J, Anderson, ME, Britton, J, Buch, MH, Del Galdo, F, Denton, CP, Dinsdale, G, Griffiths, B, Hall, F, Howell, K, MacDonald, A, McHugh, NJ, Manning, JB, Pauling, JD, Roberts, C, Shipley, JA, Herrick, AL, Murray, AK
Publikováno v:
Wilkinson, J D, Leggett, S A, Marjanovic, E J, Moore, T L, Allen, J, Anderson, M E, Britton, J, Buch, M H, Galdo, F D, Denton, C P, Dinsdale, G, Griffiths, B, Hall, F, Howell, K, MacDonald, A, McHugh, N J, Manning, J B, Pauling, J D, Roberts, C, Shipley, J A, Herrick, A L & Murray, A K 2018, ' A Multicenter Study of the Validity and Reliability of Responses to Hand Cold Challenge as Measured by Laser Speckle Contrast Imaging and Thermography : outcome measures for systemic sclerosis-related Raynaud's phenomenon ', Arthritis & Rheumatology, vol. 70, no. 6, pp. 903-911 . https://doi.org/10.1002/art.40457
Wilkinson, J D, Leggett, S A, Marjanovic, E J, Moore, T L, Allen, J, Anderson, M E, Britton, J, Buch, M H, Del Galdo, F, Denton, C P, Dinsdale, G, Griffiths, B, Hall, F, Howell, K, MacDonald, A, McHugh, N J, Manning, J B, Pauling, J D, Roberts, C, Shipley, J A, Herrick, A L & Murray, A K 2018, ' A Multicenter Study of the Validity and Reliability of Responses to Hand Cold Challenge as Measured by Laser Speckle Contrast Imaging and Thermography : Outcome Measures for Systemic Sclerosis–Related Raynaud's Phenomenon ', Arthritis and Rheumatology, vol. 70, no. 6, pp. 903-911 . https://doi.org/10.1002/art.40457, https://doi.org/10.1002/art.40457
Wilkinson, J D, Leggett, S A, Marjanovic, E J, Moore, T L, Allen, J, Anderson, M E, Britton, J, Buch, M H, Del Galdo, F, Denton, C P, Dinsdale, G, Griffiths, B, Hall, F, Howell, K, MacDonald, A, McHugh, N J, Manning, J B, Pauling, J D, Roberts, C, Shipley, J A, Herrick, A L & Murray, A K 2018, ' A Multicenter Study of the Validity and Reliability of Responses to Hand Cold Challenge as Measured by Laser Speckle Contrast Imaging and Thermography : Outcome Measures for Systemic Sclerosis–Related Raynaud's Phenomenon ', Arthritis and Rheumatology, vol. 70, no. 6, pp. 903-911 . https://doi.org/10.1002/art.40457, https://doi.org/10.1002/art.40457
Objective: Reliable and objective outcome measures to facilitate clinical trials of novel treatments for systemic sclerosis (SSc)–related Raynaud's phenomenon (RP) are badly needed. Laser speckle contrast imaging (LSCI) and thermography are noninva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6d9fe8a420bd8e3e08fab5c0015a00b8
https://purehost.bath.ac.uk/ws/files/168480216/R2_valids_30_12_17.pdf
https://purehost.bath.ac.uk/ws/files/168480216/R2_valids_30_12_17.pdf
Autor:
Gonzalez-Serna, D, Carmona, EG, Ortego-Centeno, N, Simeon, CP, Solans, R, Hernandez-Rodriguez, J, Tolosa, C, Castaneda, S, Narvaez, J, Martinez-Valle, F, European GCA Consortium, European Scleroderma Group, Witte, T, Neumann, T, Holle, J, Beretta, L, Boiardi, L, Emmi, G, Cimmino, MA, Vaglio, A, Herrick, AL, Denton, CP, Salvarani, C, Cid, MC, Morgan, AW, Fonseca, C, Gonzalez-Gay, MA, Martin, J, Marquez, A
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Digital.CSIC. Repositorio Institucional del CSIC
instname
PLoS ONE, Vol 13, Iss 12, p e0209343 (2018)
European Scleroderma Group, European GCA Consortium & Herrick, A L 2018, ' A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility ', PLoS ONE, vol. 13, no. 12, e0209343 . https://doi.org/10.1371/journal.pone.0209343
PLoS ONE 13(12): e0209343
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
Recercat. Dipósit de la Recerca de Catalunya
PLoS ONE
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Universidad de Barcelona
Digital.CSIC. Repositorio Institucional del CSIC
instname
PLoS ONE, Vol 13, Iss 12, p e0209343 (2018)
European Scleroderma Group, European GCA Consortium & Herrick, A L 2018, ' A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility ', PLoS ONE, vol. 13, no. 12, e0209343 . https://doi.org/10.1371/journal.pone.0209343
PLoS ONE 13(12): e0209343
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
Recercat. Dipósit de la Recerca de Catalunya
PLoS ONE
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
BACKGROUND: The TNFSF13B (TNF superfamily member 13b) gene encodes BAFF, a cytokine with a crucial role in the differentiation and activation of B cells. An insertion-deletion variant (GCTGT→A) of this gene, leading to increased levels of BAFF, has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dce448ef7e18e214628c1dbe43eeaa0c
http://hdl.handle.net/2158/1197241
http://hdl.handle.net/2158/1197241
Autor:
Abdulle, AE, Arends, S, van Goor, H, Brouwer, E, van Roon, AM, Westra, J, Herrick, AL, de Leeuw, K, Mulder, DJ
Publikováno v:
Scandinavian Journal of Rheumatology; Mar2021, Vol. 50 Issue 2, p153-160, 8p
Autor:
Dinsdale G, Herrick AL
Publikováno v:
Journal of Vascular Diagnostics, Vol 2014, Iss Issue 1, Pp 127-139 (2014)
Graham Dinsdale, Ariane L Herrick Centre for Musculoskeletal Research, Institute of Inflammation and Repair, Salford Royal NHS Foundation Trust, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK Abstract: Raynaud's p
Publikováno v:
Scandinavian Journal of Rheumatology; May2020, Vol. 49 Issue 3, p239-243, 5p, 1 Color Photograph, 1 Chart, 1 Graph
Autor:
Richards, HL1 (AUTHOR) hrichard@fs1.ho.man.ac.uk, Herrick, AL2 (AUTHOR), Griffin, K2 (AUTHOR), Gwilliam, PDH3 (AUTHOR), Fortune, DG1 (AUTHOR)
Publikováno v:
Psychology, Health & Medicine. Feb2004, Vol. 9 Issue 1, p29-39. 11p.
Autor:
Peytrignet, S, Manning, J, Wragg, E, Moore, T, Samaranayaka, M, Dinsdale, G, Herrick, AL, Herrick, A L
Publikováno v:
Scandinavian Journal of Rheumatology; May2019, Vol. 48 Issue 3, p230-234, 5p, 1 Chart, 2 Graphs